+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Ambulatory Surgical Centers Market Outlook 2028

  • PDF Icon

    Report

  • 113 Pages
  • August 2021
  • Region: United States
  • Research Nester Pvt. Ltd
  • ID: 5401661
Description Jump to:

The U.S. ambulatory surgical center market is expected to grow at a CAGR of 6.9% during the forecast period, i.e., 2021-2028. The demand for highly advanced surgical centers is getting stronger all across the United States. The increasing number of ambulatory surgical centers, owing to the positive government initiatives to develop advanced healthcare infrastructure offers various opportunities to expand the market growth. Companies are rigorously expanding their ambulatory surgery centers into different locations all across the United States on the back of government support, and increasing prevalence of chronic diseases. Further, growing awareness regarding the benefits of ambulatory surgical centers compared to hospitals, such as, less cost of treatment, is also estimated to drive the market growth. The market is estimated to garner a revenue of around USD 33,000 million in 2028, up from about USD 30,000 million in 2019. Increasing prevalence of chronic diseases, rising geriatric population, and high healthcare expenditure for ambulatory surgical centers are the major growth drivers for the market. Moreover, leading companies are highly focused on acquiring and merging with numerous hospitals and freestanding surgery centers. For instance, Tenet Healthcare Corporation announced that it plans to acquire 45 ambulatory surgical centers from SurgCenter Development. This is estimated to encourage the market growth in the future. The U.S. ambulatory surgical center market is segmented by type, specialty, ownership, and treatment. On the basis of ownership, the market is segmented into corporate-physician, hospital-physician, corporate-hospital, corporate only, physician only, and hospital only. Out of these, the physician-only segment is expected to attain the largest market revenue of close to USD 21600 million by 2028. Physicians have witnessed a decline in reimbursement from insurers and have invested in ASCs to offer diagnostic and treatment procedures, which is estimated to drive the growth of the segment.



The U.S. ambulatory surgical center market is further segmented by region into West US, North East US, South East US, South West US, and Midwest US. The market in West US region is estimated to witness growth by a CAGR of 8% approximately over the forecast period owing to the high number of surgical centers in regions owing to the high government spending on healthcare resources along with favorably changing regulatory landscape affecting the investors. The market in the North East US is estimated to garner a revenue of USD 8,616 million in 2028, from USD 7,890 million in 2019.



Some of the key players in the U.S. ambulatory surgical center market that are mentioned in our report are TH Medical, AMSURG Corp. (Envision Healthcare), Surgical Care Affiliates, SurgCenter, Regent Surgical Health, ASD Management, Ambulatory Surgical Centers of America, Physicians Endoscopy, LLC, Surgery Partners, and others.


Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. Executive Summary- U.S. Ambulatory Surgical Centers Market
5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Trends
5.4. Opportunities
6. Regulatory Landscape7. Patient Epidemiology Analysis8. Pricing Analysis9. Comparative Analysis of Payer System in U.S.10. Impact Of Covid-19 On the U.S. Ambulatory Surgical Centers Market11. Key Market Opportunities12. Analysis On the Number of ASCs in The United States
13. Competitive Landscape
13.1. Competitive Benchmarking of Key Players
13.2. Company Profiles
13.2.1. TH Medical
13.2.2. AMSURG Corp. (Envision Healthcare)
13.2.3. Surgical Care Affiliates
13.2.4. SurgCenter
13.2.5. Regent Surgical Health
13.2.6. ASD Management
13.2.7. Physicians Endoscopy, LLC
13.2.8. Ambulatory Surgical Centers of America
13.2.9. Surgery Partners
13.2.10. Other Prominent Players
14. U.S. Ambulatory Surgical Centers Market Outlook
14.1. Market Value (USD Million)
14.2. U.S. Ambulatory Surgical Centers Market Segmentation Analysis 2019-2028
14.2.1. By Type
14.2.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
14.2.1.2. Freestanding ASCs, 2019-2028F (USD Million)
14.2.2. By Specialty
14.2.2.1. Single Specialty Centers, 2019-2028F (USD Million)
14.2.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
14.2.3. By Ownership
14.2.3.1. Corporate Physician, 2019-2028F (USD Million)
14.2.3.2. Hospital Physician, 2019-2028F (USD Million)
14.2.3.3. Corporate Hospital, 2019-2028F (USD Million)
14.2.3.4. Corporate Only, 2019-2028F (USD Million)
14.2.3.5. Physician Only, 2019-2028F (USD Million)
14.2.3.6. Hospital Only, 2019-2028F (USD Million)
14.2.4. By Treatment
14.2.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
14.2.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
14.2.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
14.2.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
14.2.4.1.4. Ankle Repair, 2019-2028F (USD Million)
14.2.4.1.5. Others, 2019-2028F (USD Million)
14.2.4.2. Dental, 2019-2028F (USD Million)
14.2.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
14.2.4.2.2. Others, 2019-2028F (USD Million)
14.2.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
14.2.4.3.1. Lasik, 2019-2028F (USD Million)
14.2.4.3.2. Cataract, 2019-2028F (USD Million)
14.2.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
14.2.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
14.2.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
14.2.4.4. Endoscopy, 2019-2028F (USD Million)
14.2.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
14.2.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
14.2.4.5.2. Colposcopy, 2019-2028F (USD Million)
14.2.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
14.2.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
14.2.4.5.5. Others, 2019-2028F (USD Million)
14.2.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
14.2.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
14.2.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
14.2.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
14.2.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
14.2.4.6.5. Others, 2019-2028F (USD Million)
14.2.4.7. Pain Management, 2019-2028F (USD Million)
14.2.4.8. Ent Surgeries, 2019-2028F (USD Million)
14.2.4.9. Neurosurgery, 2019-2028F (USD Million)
14.2.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
14.2.4.11. Plastic Surgery, 2019-2028F (USD Million)
14.2.4.12. Others, 2019-2028F (USD Million)
15. U.S. Ambulatory Surgical Centers Market Outlook, By Region
15.1. West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.2. Market Value (USD Million)
15.2.1. By Type
15.2.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.2.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.2.2. By Specialty
15.2.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.2.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.2.3. By Ownership
15.2.3.1. Corporate Physician, 2019-2028F (USD Million)
15.2.3.2. Hospital Physician, 2019-2028F (USD Million)
15.2.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.2.3.4. Corporate Only, 2019-2028F (USD Million)
15.2.3.5. Physician Only, 2019-2028F (USD Million)
15.2.3.6. Hospital Only, 2019-2028F (USD Million)
15.2.4. By Treatment
15.2.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.2.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.2.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.2.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.2.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.2.4.1.5. Others, 2019-2028F (USD Million)
15.2.4.2. Dental, 2019-2028F (USD Million)
15.2.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.2.4.2.2. Others, 2019-2028F (USD Million)
15.2.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.2.4.3.1. Lasik, 2019-2028F (USD Million)
15.2.4.3.2. Cataract, 2019-2028F (USD Million)
15.2.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.2.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.2.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.2.4.4. Endoscopy, 2019-2028F (USD Million)
15.2.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.2.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.2.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.2.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.2.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.2.4.5.5. Others, 2019-2028F (USD Million)
15.2.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.2.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.2.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.2.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.2.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.2.4.6.5. Others, 2019-2028F (USD Million)
15.2.4.7. Pain Management, 2019-2028F (USD Million)
15.2.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.2.4.9. Neurosurgery, 2019-2028F (USD Million)
15.2.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.2.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.2.4.12. Others, 2019-2028F (USD Million)
15.3. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.4. Market Value (USD Million)
15.4.1. By Type
15.4.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.4.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.4.2. By Specialty
15.4.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.4.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.4.3. By Ownership
15.4.3.1. Corporate Physician, 2019-2028F (USD Million)
15.4.3.2. Hospital Physician, 2019-2028F (USD Million)
15.4.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.4.3.4. Corporate Only, 2019-2028F (USD Million)
15.4.3.5. Physician Only, 2019-2028F (USD Million)
15.4.3.6. Hospital Only, 2019-2028F (USD Million)
15.4.4. By Treatment
15.4.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.4.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.4.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.4.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.4.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.4.4.1.5. Others, 2019-2028F (USD Million)
15.4.4.2. Dental, 2019-2028F (USD Million)
15.4.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.4.4.2.2. Others, 2019-2028F (USD Million)
15.4.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.4.4.3.1. Lasik, 2019-2028F (USD Million)
15.4.4.3.2. Cataract, 2019-2028F (USD Million)
15.4.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.4.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.4.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.4.4.4. Endoscopy, 2019-2028F (USD Million)
15.4.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.4.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.4.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.4.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.4.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.4.4.5.5. Others, 2019-2028F (USD Million)
15.4.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.4.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.4.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.4.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.4.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.4.4.6.5. Others, 2019-2028F (USD Million)
15.4.4.7. Pain Management, 2019-2028F (USD Million)
15.4.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.4.4.9. Neurosurgery, 2019-2028F (USD Million)
15.4.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.4.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.4.4.12. Others, 2019-2028F (USD Million)
15.5. South East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.6. Market Value (USD Million)
15.6.1. By Type
15.6.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.6.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.6.2. By Specialty
15.6.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.6.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.6.3. By Ownership
15.6.3.1. Corporate Physician, 2019-2028F (USD Million)
15.6.3.2. Hospital Physician, 2019-2028F (USD Million)
15.6.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.6.3.4. Corporate Only, 2019-2028F (USD Million)
15.6.3.5. Physician Only, 2019-2028F (USD Million)
15.6.3.6. Hospital Only, 2019-2028F (USD Million)
15.6.4. By Treatment
15.6.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.6.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.6.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.6.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.6.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.6.4.1.5. Others, 2019-2028F (USD Million)
15.6.4.2. Dental, 2019-2028F (USD Million)
15.6.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.6.4.2.2. Others, 2019-2028F (USD Million)
15.6.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.6.4.3.1. Lasik, 2019-2028F (USD Million)
15.6.4.3.2. Cataract, 2019-2028F (USD Million)
15.6.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.6.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.6.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.6.4.4. Endoscopy, 2019-2028F (USD Million)
15.6.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.6.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.6.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.6.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.6.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.6.4.5.5. Others, 2019-2028F (USD Million)
15.6.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.6.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.6.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.6.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.6.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.6.4.6.5. Others, 2019-2028F (USD Million)
15.6.4.7. Pain Management, 2019-2028F (USD Million)
15.6.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.6.4.9. Neurosurgery, 2019-2028F (USD Million)
15.6.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.6.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.6.4.12. Others, 2019-2028F (USD Million)
15.7. South West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.8. Market Value (USD Million)
15.8.1. By Type
15.8.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.8.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.8.2. By Specialty
15.8.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.8.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.8.3. By Ownership
15.8.3.1. Corporate Physician, 2019-2028F (USD Million)
15.8.3.2. Hospital Physician, 2019-2028F (USD Million)
15.8.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.8.3.4. Corporate Only, 2019-2028F (USD Million)
15.8.3.5. Physician Only, 2019-2028F (USD Million)
15.8.3.6. Hospital Only, 2019-2028F (USD Million)
15.8.4. By Treatment
15.8.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.8.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.8.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.8.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.8.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.8.4.1.5. Others, 2019-2028F (USD Million)
15.8.4.2. Dental, 2019-2028F (USD Million)
15.8.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.8.4.2.2. Others, 2019-2028F (USD Million)
15.8.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.8.4.3.1. Lasik, 2019-2028F (USD Million)
15.8.4.3.2. Cataract, 2019-2028F (USD Million)
15.8.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.8.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.8.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.8.4.4. Endoscopy, 2019-2028F (USD Million)
15.8.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.8.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.8.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.8.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.8.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.8.4.5.5. Others, 2019-2028F (USD Million)
15.8.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.8.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.8.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.8.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.8.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.8.4.6.5. Others, 2019-2028F (USD Million)
15.8.4.7. Pain Management, 2019-2028F (USD Million)
15.8.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.8.4.9. Neurosurgery, 2019-2028F (USD Million)
15.8.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.8.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.8.4.12. Others, 2019-2028F (USD Million)
15.9. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
15.10. Market Value (USD Million)
15.10.1. By Type
15.10.1.1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
15.10.1.2. Freestanding ASCs, 2019-2028F (USD Million)
15.10.2. By Specialty
15.10.2.1. Single Specialty Centers, 2019-2028F (USD Million)
15.10.2.2. Multi-Specialty Centers, 2019-2028F (USD Million)
15.10.3. By Ownership
15.10.3.1. Corporate Physician, 2019-2028F (USD Million)
15.10.3.2. Hospital Physician, 2019-2028F (USD Million)
15.10.3.3. Corporate Hospital, 2019-2028F (USD Million)
15.10.3.4. Corporate Only, 2019-2028F (USD Million)
15.10.3.5. Physician Only, 2019-2028F (USD Million)
15.10.3.6. Hospital Only, 2019-2028F (USD Million)
15.10.4. By Treatment
15.10.4.1. Orthopedic Surgeries, 2019-2028F (USD Million)
15.10.4.1.1. Spinal Surgeries, 2019-2028F (USD Million)
15.10.4.1.2. Knee Replacement Surgeries, 2019-2028F (USD Million)
15.10.4.1.3. Joint Replacement Surgeries, 2019-2028F (USD Million)
15.10.4.1.4. Ankle Repair, 2019-2028F (USD Million)
15.10.4.1.5. Others, 2019-2028F (USD Million)
15.10.4.2. Dental, 2019-2028F (USD Million)
15.10.4.2.1. Maxillofacial Surgeries, 2019-2028F (USD Million)
15.10.4.2.2. Others, 2019-2028F (USD Million)
15.10.4.3. Ophthalmology Surgeries, 2019-2028F (USD Million)
15.10.4.3.1. Lasik, 2019-2028F (USD Million)
15.10.4.3.2. Cataract, 2019-2028F (USD Million)
15.10.4.3.3. Glaucoma Surgery, 2019-2028F (USD Million)
15.10.4.3.4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
15.10.4.3.5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
15.10.4.4. Endoscopy, 2019-2028F (USD Million)
15.10.4.5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
15.10.4.5.1. Adhesiolysis, 2019-2028F (USD Million)
15.10.4.5.2. Colposcopy, 2019-2028F (USD Million)
15.10.4.5.3. Endometrial Ablation, 2019-2028F (USD Million)
15.10.4.5.4. Cervical Biopsy, 2019-2028F (USD Million)
15.10.4.5.5. Others, 2019-2028F (USD Million)
15.10.4.6. Cardiovascular Surgeries, 2019-2028F (USD Million)
15.10.4.6.1. Aortic Surgery, 2019-2028F (USD Million)
15.10.4.6.2. Heart Valve Repair, 2019-2028F (USD Million)
15.10.4.6.3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
15.10.4.6.4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
15.10.4.6.5. Others, 2019-2028F (USD Million)
15.10.4.7. Pain Management, 2019-2028F (USD Million)
15.10.4.8. Ent Surgeries, 2019-2028F (USD Million)
15.10.4.9. Neurosurgery, 2019-2028F (USD Million)
15.10.4.10. Gastrointestinal Surgery, 2019-2028F (USD Million)
15.10.4.11. Plastic Surgery, 2019-2028F (USD Million)
15.10.4.12. Others, 2019-2028F (USD Million)

Companies Mentioned

  • TH Medical
  • AMSURG Corp. (Envision Healthcare)
  • Surgical Care Affiliates
  • SurgCenter
  • Regent Surgical Health
  • ASD Management
  • Ambulatory Surgical Centers of America
  • Physicians Endoscopy LLC
  • Surgery Partners

Related Topics

Related Reports

Ambulatory Surgery Center Global Market Report 2024 - Product Image

Ambulatory Surgery Center Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Ambulatory Surgical Centers IT Services Global Market Report 2024 - Product Image

Ambulatory Surgical Centers IT Services Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
U.S. Ambulatory Surgery Center Market Size, Share & Trends Analysis Report by Specialty (Orthopedics, Otolaryngology), Ownership (Physician, Hospital) by Center Type (Single, Multispecialty), Device Type, Region, and Segment Forecasts, 2024-2030 - Product Image

U.S. Ambulatory Surgery Center Market Size, Share & Trends Analysis Report by Specialty (Orthopedics, Otolaryngology), Ownership (Physician, Hospital) by Center Type (Single, Multispecialty), Device Type, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • United States
From
Ambulatory Surgical Centers Market by Specialty, Type, Treatment, Specialties Served - Global Forecast 2025-2030 - Product Image

Ambulatory Surgical Centers Market by Specialty, Type, Treatment, Specialties Served - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Ambulatory Surgical Centers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Ambulatory Surgical Centers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.